Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-10-17
1990-08-21
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514465, H61K 3144, H61K 3136
Patent
active
049506803
ABSTRACT:
Compositions and a method for inhibiting tumor cell induced platelet aggregation are described. Platelet aggregation by tumor cells is part of the metastatic cascade which is interrupted according to the present invention. The compounds include a mixture of at least two members of the group including a calcium channel blocker, a prostacyclin, a thromboxane synthase inhibitor and a phosphodiesterase inhibitor. All of the compounds utilized have an affect on calcium ion which controls platelet aggregation.
REFERENCES:
Gordon, J. L. In: Platelets in Biology and Pathology-2 (J. L. Gordon, ed) Elsevier North Holland Biomedical Press, Amsterdam pp. 2-7 (1981).
Weiss, H. J. In: Platelets: Pathophysiology and Antiplatelet Drug Therapy. Alan R. Liss, Inc., New York pp. 13-17, 1982.
Jamieson, G. A., et al., In: Interaction of Platelets and Tumor Cells. Alan R. Liss, Inc., New York, pp. 405-413.
Gasic, G. J., et al., Int. J. Cancer 11:704-718, 1973.
Hara, H., et al., Cancer Res. 40:1217-1222, 1980.
Bastida, E., et al., Nature 291:661-662, 1981.
Gasic, G. J., et al., Proc. Natl. Acad. Sci. USA 61:46-52, 1968.
Honn, K. V., et al., Science 212:1270-1272, 1981.
Menter, D., et al., In: Prostaglandins and Cancer. First Intl. Conf. pp. 809-813, 1982.
Shaw, J. O. et al. Biochim. Biophys. Acta 714:492-499, 1982.
Imai, A., et al., Biochem. Biophys. Res. Commun. 108:(2)752-759, 1982.
Gerrard, J. M., et al., In: Platelets in Biology and Pathology--2 J. L. Gordon, ed., North Holland Biomedical Press, Amsterdam, pp. 407-436, 1981.
Rittenhouse-Simmons, S. J. Biol. Chem. 256:(9)4155, 1981.
Shukla, S. D. Life Sciences 30:1323-1335, 1982.
Serhan, C. N., et al., J. Biol. Chem. 257:(9) 4746-4752, 1982.
Gorman, R. R. Fed. Proc. 38:(1)83-88, 1979.
Parise, L. V., et al., J. Pharm. Expotl. Therap. 222:(1)276-281, 1982.
Vargaftig, B. B., et al., Biochem. Pharmacol. 30 263-271 (1981).
Hamberg, M., et al., Proc. Natl. Acad. Sci. USA 72:2994, 1975.
Heptinstall, S., et al., Thromb. Res. 20:219, 1980.
Moncada, S., et al., Nature 263:663, 1976.
Moncada, S., et al., In:Biochemical Aspects of Prostaglandins and Thromboxanes, (Eds. N. Kharasch and J. Fried), p. 155. Academic Press, New York, 1977.
Mullane, K. M., et al. Eur. J. Pharmacol. 54:217, 1979.
Moncada, S., et al., Prostaglandins. 12:715, 1971.
Szczeklik, A., et al., J. Pharmacol. Res. Commun. 10:545, 1978.
Gastpar, H., J. Medicine 8(2):103-114, 1977.
Bastida, E., et al., Cancer Res. 42:4348-4352, 1982.
Paschen, W., et al., P. Blut 38:17-24, 1979.
Honn, K. V., et al., Acta Clinica Belgica, in press, 1983.
Honn, K. V., et al., Biochem. Pharm., in press, 1983.
Owen, N. E., et al. Am. J. Physiol. 239:483-488, 1980.
Schumunk, G. A. et al., Res. Commun. Chem. Path. and Pharm. 35:(2) 179-187, 1982.
Owen, N. E. et al., Am. J. Physiol. 241:613-619, 1981.
Menter, et al., Cancer Research, 44, 450-456, 1984.
Honn, K., et al., Clinical and Exp. Metastasis 1:103-114 (1983).
Fleckenstein A., An. Rev. Pharmacol. Toxicol. 17:149-166 (1977).
Murphy KMM, Gould RJ, Largent BL and Snyder SH. Proc. Natl. Acad. Sci. USA 80:860-864, (1983).
Nayler WG and Grinwald P. Fed. Proc. Fed. Am. Soc. Exp. Biol. 40:2855-2861, 1981).
Lee KS and Tsien RW. Nature (London) 302:790-794, (1983).
Mustard et al., Br. J. Haemotology, 1972, 22:193-204.
Exptl. Cell Res. 13:341-347 (1957), Phillips.
Anal. Biochem. 98:112-115, 1979, Grant.
Diglio, C. A., Grammas, P., Giacomelli, F. and Wiener, Lab. Investigations, vol. 46, No. 6, p. 554 (1982).
Honn Kenneth V.
Taylor John D.
Board of Governors of Wayne State University
Goldberg Jerome D.
McLeod Ian C.
LandOfFree
Method and compositions for inhibition of tumor cell induced pla does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and compositions for inhibition of tumor cell induced pla, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and compositions for inhibition of tumor cell induced pla will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1677965